Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karn Wijarnpreecha

Showing results (251-260 of 267) with videos related to

Pageof 27
Sort By:
Alimentary Pharmacology & Therapeutics|October 28, 2024
Prevalence of Low FIB-4 in MASLD-Related Hepatocellular Carcinoma: A Multicentre StudyDarren Jun Hao Tan, Nobuharu Tamaki, Beom Kyung Kim, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 10, 2025
The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021Ethan Kai Jun Tham, Darren Jun Hao Tan, Pojsakorn Danpanichkul, et al.
Digestive Diseases and Sciences|April 4, 2026
Impact of Transjugular Intrahepatic Portosystemic Shunt on Waitlist and Post-transplant Outcomes in Liver Transplant CandidatesRyan Yanzhe Lim, Peter Jin Sun Low, Wen Hui Lim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 24, 2025
Impact of Model for End-stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-associated Steatohepatitis Cirrhosis Among Liver Transplant CandidatesWen Hui Lim, Darren Jun Hao Tan, Kartik Mitra, et al.
United European Gastroenterology Journal|July 3, 2025
The Rising Global Burden of MASLD and Other Metabolic Diseases (2000-2021)Pojsakorn Danpanichkul, Kanokphong Suparan, Luis Antonio Diaz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 11, 2025
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-analysisRyan Yanzhe Lim, Faith Xin Ning Tan, Glenn Jun Kit Ho, et al.
Journal of Hepatology|October 31, 2024
Liver cancer in 2021: Global Burden of Disease studyEn Ying Tan, Pojsakorn Danpanichkul, Jie Ning Yong, et al.
Transplantation|June 16, 2026
Delisting From Clinical Improvement in Liver Cirrhosis: A Machine Learning Decision Tree AnalysisNicole Shu Ying Tang, Margaret L P Teng, Asvin Selvakumar, et al.
Mayo Clinic Proceedings|February 13, 2025
Early-Onset Gastrointestinal Cancers and Metabolic Risk Factors: Global Trends From the Global Burden of Disease Study 2021Pojsakorn Danpanichkul, Kanokphong Suparan, Thanida Auttapracha, et al.
Cell Reports. Medicine|March 18, 2026
Suboptimal therapeutic responses associated with semaglutide in type 2 diabetes and obesity: A meta-analysis of randomized controlled trialsDonghyun Ko, Do Han Kim, Faith Xin Ning Tan, et al.
Pageof 27

Showing results (251-260 of 267) with videos related to

Sort By:
Pageof 27
Alimentary Pharmacology & Therapeutics|October 28, 2024
Prevalence of Low FIB-4 in MASLD-Related Hepatocellular Carcinoma: A Multicentre StudyDarren Jun Hao Tan, Nobuharu Tamaki, Beom Kyung Kim, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 10, 2025
The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021Ethan Kai Jun Tham, Darren Jun Hao Tan, Pojsakorn Danpanichkul, et al.
Digestive Diseases and Sciences|April 4, 2026
Impact of Transjugular Intrahepatic Portosystemic Shunt on Waitlist and Post-transplant Outcomes in Liver Transplant CandidatesRyan Yanzhe Lim, Peter Jin Sun Low, Wen Hui Lim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 24, 2025
Impact of Model for End-stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-associated Steatohepatitis Cirrhosis Among Liver Transplant CandidatesWen Hui Lim, Darren Jun Hao Tan, Kartik Mitra, et al.
United European Gastroenterology Journal|July 3, 2025
The Rising Global Burden of MASLD and Other Metabolic Diseases (2000-2021)Pojsakorn Danpanichkul, Kanokphong Suparan, Luis Antonio Diaz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 11, 2025
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-analysisRyan Yanzhe Lim, Faith Xin Ning Tan, Glenn Jun Kit Ho, et al.
Journal of Hepatology|October 31, 2024
Liver cancer in 2021: Global Burden of Disease studyEn Ying Tan, Pojsakorn Danpanichkul, Jie Ning Yong, et al.
Transplantation|June 16, 2026
Delisting From Clinical Improvement in Liver Cirrhosis: A Machine Learning Decision Tree AnalysisNicole Shu Ying Tang, Margaret L P Teng, Asvin Selvakumar, et al.
Mayo Clinic Proceedings|February 13, 2025
Early-Onset Gastrointestinal Cancers and Metabolic Risk Factors: Global Trends From the Global Burden of Disease Study 2021Pojsakorn Danpanichkul, Kanokphong Suparan, Thanida Auttapracha, et al.
Cell Reports. Medicine|March 18, 2026
Suboptimal therapeutic responses associated with semaglutide in type 2 diabetes and obesity: A meta-analysis of randomized controlled trialsDonghyun Ko, Do Han Kim, Faith Xin Ning Tan, et al.
Pageof 27